Business Context and Reporting Period
Granite Point Mortgage Trust Inc. (GPMT) filed a Form 8-K on November 16, 2021, reporting the entry into a material definitive agreement. The Company established a new collateralized loan obligation (CLO) vehicle, "GPMT 2021-FL4" (the "FL4 CLO"), through wholly owned subsidiaries. The transaction closed on November 16, 2021, involving the issuance of various classes of notes and preferred shares to fund a portfolio of commercial real estate loans.
Key Financial Metrics and Transaction Structure
The FL4 CLO transaction involved the issuance of securities with an aggregate principal amount of approximately $626.5 million in notes and $54.4 million in preferred shares. The capital structure is as follows:
- Class A Notes: $344.88 million (AAA/Aaa rated, 1.35% - 1.60% spread over Benchmark).
- Class A-S Notes: $19.42 million (AAA rated, 1.70% - 1.95% spread).
- Class B Notes: $35.73 million (AA(low) rated, 1.95% - 2.45% spread).
- Class C Notes: $42.72 million (A(low) rated, 2.35% - 2.85% spread).
- Class D Notes: $48.16 million (BBB rated, 2.85% - 3.35% spread).
- Class E Notes: $11.65 million (BBB(low) rated, 3.45% - 3.95% spread).
- Class F Notes (Retained): $39.62 million (BB(low) rated, 4.50% spread).
- Class G Notes (Retained): $24.86 million (B(low) rated, 6.00% spread).
- Preferred Shares: 54,373,442 shares with a $1,000 liquidation preference ($54.37 million notional).
Collateral: Proceeds were used to purchase commercial real estate whole loans and participations with an aggregate principal balance of approximately $584.3 million as of the October 9, 2021 cut-off date. An additional $37.1 million was reserved for delayed close purchases.
Liquidity and Debt: The filing does not provide consolidated balance sheet data for the parent company. The CLO structure is a limited recourse obligation; the Company retained the junior Class F and G notes and preferred shares to comply with risk retention rules.
Material Changes and Transaction Details
This filing represents a significant expansion of the Company's CLO platform. The primary material change is the creation of the FL4 CLO vehicle and the associated debt obligations. The transaction includes a 24-month reinvestment period allowing the Collateral Manager to reinvest proceeds into eligible commercial real estate loans. The Company guaranteed the repurchase obligation of the FL4 Seller in the event of a material breach of representations and warranties regarding the collateral.
Outlook, Risks, and Management Commentary
Management Commentary: The transaction was executed to deploy capital into commercial real estate assets. The Collateral Manager (GPMT Collateral Manager LLC) has waived its management fee for the duration of its tenure, though this is not guaranteed for future managers.
Risks and Contingencies:
- Interest Deferral: Interest on junior notes (Classes C, D, E, F, G) may be deferred if funds are insufficient to pay senior notes, without constituting an event of default.
- Protection Tests: The CLO is subject to a Par Value Test (122.41%) and an Interest Coverage Test (120.00%). Failure to meet these tests triggers mandatory principal paydowns of senior notes.
- Collateral Risk: The weighted average life assumptions assume no defaults or extensions. Actual performance may vary.
- Recourse Limitation: Obligations are limited recourse; if collateral liquidation is insufficient, the deficiency is extinguished.
Investor Verification Checklist
- Verify the specific composition and credit quality of the $584.3 million initial collateral pool.
- Confirm the status of the $37.1 million delayed close account and the identity of the two pre-identified loans.
- Review the full text of the Indenture (Exhibit 10.1) for detailed priority of payments and default triggers.
- Assess the impact of the retained junior notes (Classes F and G) on the Company's consolidated leverage and earnings volatility.
- Monitor the Collateral Manager's ability to meet the 122.41% Par Value Test and 120.00% Interest Coverage Test in future reporting periods.